CAMBRIDGE, MA, November 6, 2017 - PROMETRIKA, LLC(www.prometrika.com), a full-service Clinical Research Organization, has announced it will take an active role at Medidata NEXT Global 2017 in New York, November 8-10. This event offers keynote speakers, breakout sessions, and interactive learning opportunities for industry leaders around the globe. Medidata NEXT Global is the centerpiece of the largest annual event series of its kind, attracting over 3,000 attendees across events in Basel, Berlin, London, New York, Seoul, Shanghai and Tokyo.
“I am pleased that three of PROMETRIKA’s team members were selected by Medidata to share their experiences with Medidata’s suite of trial enhancement products,” said Miganush Stepanians, PhD, President and CEO of PROMETRIKA. “PROMETRIKA is a Medidata Rave® Partner and has always been an early adopter of Medidata’s solutions. We are eager to engage in compelling discussions of best practices in technology solutions with our colleagues in the industry.”
PROMETRIKA team members will present in three sessions:
Study Conduct I: Study Conduct Medical Coding (Keys to Success in Medical Coding From A to Z) Cathy Hult, Senior Manager, Data Management. Thursday, November 9.
Cathy will speak about PROMETRIKA’s recent experience implementing Medidata Coder® after many years of using an external, standalone, coding tool. Medidata Coder is integrated with Rave EDC, offering real time coding of verbatim terms and enhancing coding consistency review process.DOWNLOAD PRESENTATION PDF VIEW PRESENTATION VIDEO
Patient Engagement: ePRO Data Integration with Rave: Case Studies With and Without Patient Cloud. Kathy Zheng, MPH, Senior Project Manager. Friday, November 10.
In this presentation, Kathy will describe PROMETRIKA’s most recent experiences with ePRO solutions, demonstrating the differences between integrating an external ePRO solution with Medidata Rave, versus implementing a solution within the Medidata suite of products.DOWNLOAD PRESENTATION PDF VIEW PRESENTATION VIDEO
Support Site: SDV…What is it Good For? Absolutely Nothing? Stephen Cropper, Senior Clinical Research Associate, Clinical Operations. Friday, November 10.
In his presentation, Stephen will address technological improvements in the field of clinical trial monitoring that have improved data review. He also will discuss data management tools intended to produce smart, accurate, and efficient data results.DOWNLOAD PRESENTATION PDF
“PROMETRIKA has been a strong partner with Medidata for several years,” said Simon Mouyal, Chief Marketing Officer of Medidata. “We were delighted to include three of their presentations for this year’s event. We’re excited for them to share their insight and achievements in clinical trial innovation.”
ABOUT PROMETRIKA, LLC - WWW.PROMETRIKA.COM
Founded in 2003 and based in Cambridge, Massachusetts, PROMETRIKA is a unique Clinical Research Organization, utilizing a collaborative approach to clinical development and execution with a close-knit, highly-experienced senior leadership team that remains involved throughout the duration of each trial. PROMETRIKA’s services include complete clinical operations and clinical trial management, data management, pharmacovigilance, biostatistics and programming, medical writing, and regulatory submissions.
Medidata is reinventing global drug and medical device development by creating the industry’s leading cloud-based solutions for clinical research. Through our advanced applications and intelligent data analytics, Medidata helps advance the scientific goals of life sciences customers worldwide, including over 950 global pharmaceutical companies, innovative biotech, diagnostic and device firms, leading academic medical centers, and contract research organizations.
The Medidata Clinical Cloud® brings a new level of quality and efficiency to clinical trials that empower our customers to make more informed decisions earlier and faster. Our unparalleled clinical trial data assets provide deep insights that pave the way for future growth. The Medidata Clinical Cloud is the primary technology solution powering clinical trials for 18 of the world’s top 25 global pharmaceutical companies and is used by 18 of the top 25 medical device developers— from study design and planning through execution, management and reporting.